drugset / Trial / NCT00715572

Combined Therapy With L-Thyroxine and L-Triiodothyronine Compared to L-Thyroxine Alone

NCT00715572

RandomizedCrossoverOpen-labelTreatment

Summary

The objective of this study was to analyze the features of monotherapy with L-T4 in comparison with combined therapy with L-T4 and L-T3 in patients with primary hypothyroidism.

Timeline

Start
2002-03
Primary completion
2004-02
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levothyroxine Other / unclassified 1.6 ug/kg
Comparator Liothyronine Small molecule 12.5 ug

Indications